A detailed history of Zevin Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Zevin Asset Management LLC holds 76,023 shares of ABBV stock, worth $13.3 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares
76,023
Previous 77,291 1.64%
Holding current value
$13.3 Million
Previous $13.3 Million 13.25%
% of portfolio
2.32%
Previous 2.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $207,749 - $252,750
-1,268 Reduced 1.64%
76,023 $15 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $700,889 - $818,481
-4,528 Reduced 5.53%
77,291 $13.3 Million
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $127,696 - $145,497
-799 Reduced 0.97%
81,819 $14.9 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $47,747 - $53,774
-347 Reduced 0.42%
82,618 $12.8 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $266,645 - $308,681
1,996 Added 2.47%
82,965 $12.4 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $63,472 - $78,987
479 Added 0.6%
80,969 $10.9 Million
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $336,652 - $387,705
-2,328 Reduced 2.81%
80,490 $12.8 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $241,904 - $290,106
-1,749 Reduced 2.07%
82,818 $13.4 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $283,719 - $325,408
2,114 Added 2.56%
84,567 $11.4 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $537,818 - $683,743
-3,908 Reduced 4.53%
82,453 $12.6 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $590,610 - $732,781
-4,475 Reduced 4.93%
86,361 $14 Million
Q4 2021

Jan 27, 2022

BUY
$107.43 - $135.93 $122,147 - $154,552
1,137 Added 1.27%
90,836 $12.3 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $702,559 - $797,510
6,603 Added 7.95%
89,699 $9.68 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $273,546 - $304,746
2,600 Added 3.23%
83,096 $9.36 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $248,998 - $274,117
2,434 Added 3.12%
80,496 $8.71 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $238,652 - $322,206
2,965 Added 3.95%
78,062 $8.36 Million
Q3 2020

Nov 04, 2020

BUY
$85.91 - $100.83 $182,644 - $214,364
2,126 Added 2.91%
75,097 $6.58 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $16,654 - $22,286
227 Added 0.31%
72,971 $7.16 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $193,435 - $293,272
2,999 Added 4.3%
72,744 $5.54 Million
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $25,534 - $31,948
354 Added 0.51%
69,745 $6.18 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $54,855 - $65,952
871 Added 1.27%
69,391 $5.25 Million
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $18,330 - $23,430
279 Added 0.41%
68,520 $4.98 Million
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $12,728 - $14,980
-165 Reduced 0.24%
68,241 $5.5 Million
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $138,728 - $171,089
-1,782 Reduced 2.54%
68,406 $6.31 Million
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $174,708 - $194,220
-1,965 Reduced 2.72%
70,188 $6.64 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $1.16 Million - $1.37 Million
-12,892 Reduced 15.16%
72,153 $6.69 Million
Q1 2018

Apr 30, 2018

SELL
$92.01 - $123.21 $1.86 Million - $2.49 Million
-20,180 Reduced 19.18%
85,045 $8.05 Million
Q4 2017

Feb 05, 2018

SELL
$89.56 - $98.21 $376,420 - $412,776
-4,203 Reduced 3.84%
105,225 $10.2 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $7.64 Million - $9.76 Million
109,428
109,428 $9.72 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Zevin Asset Management LLC Portfolio

Follow Zevin Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zevin Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zevin Asset Management LLC with notifications on news.